In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on mycobacterium tuberculosis isolates [Mycobacterium tuberculosis kökenleri üzerine siprofloksasin, levofloksasin ve moksifloksasinin in vitro etkinliği]
Küçük Resim Yok
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Ankara University
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
In vitro effects of ciprofloxacin, levofloxacin and Moxifloxacin on Mycobacterium tuberculosis isolates Introduction: Increased tuberculosis prevalence, and isolation of multidrug resistant (MDR) Mycobacterium tuberculosis strains frequently as causative organisms from tuberculosis infections are resulted in increasing need of new anti-tuberculosis drugs. Nowadays, fluoroquinolones known to have fewer side effects than the other drugs used in treatment of tuberculosis are sometimes assessed even as first-line anti-tuberculosis drugs due to their in vitro and in vivo strong activity. It was aimed in this study to investigate phenotypically the fluoroquinolone susceptibility in MDR and non-MDR M. tuberculosis isolates. Materials and Methods: A total of 126 MDR and non-MDR M. tuberculosis isolates from mycobacteriology laboratory of two hospitals in the Aegean Region of Turkey were included in the study. Ciprofloxacin (CIP), levofloxacin (LEV) and moxifloxacin (MXF) susceptibilities were assessed by agar proportion method according to the Clinical and Laboratory Standards Institute (CLSI) recommendations. Results: Twelve (15.2%), 5 (6.3%) and 4 (5.1%) of the MDR M. tuberculosis strains were resistant to CIP, LEV, MXF, respectively [resistance breakpoints (µg/mL); CIP (> 2), LEV (> 1), MXF (> 0.5)] while non-MDR strains were susceptible to CIP, LEV, MXF. Conclusion: Consequently, although high fluoroquinolone susceptibilities were evaluated as a pleasing data in this study, to preserve their efficiency for many years steadily, quinolone usage and resistance increment in MDR M. tuberculosis isolates should be monitored elaborately. © 2018, Ankara University. All rights reserved.
Açıklama
Anahtar Kelimeler
Fluoroquinolones, Multidrug resistance (MDR), Mycobacterium tuberculosis
Kaynak
Tuberkuloz ve Toraks
WoS Q Değeri
Scopus Q Değeri
Q3
Cilt
66
Sayı
1
